Literature DB >> 24513466

Impact of previous coronary artery bypass grafting on patients undergoing transcatheter aortic valve implantation for aortic stenosis.

Sa'ar Minha1, Marco A Magalhaes1, Israel M Barbash1, Itsik Ben-Dor1, Danny Dvir1, Petros G Okubagzi1, Fang Chen1, Rebecca Torguson1, Kenneth M Kent1, William O Suddath1, Lowell F Satler1, Augusto D Pichard1, Ron Waksman2.   

Abstract

Re-operation after coronary artery bypass grafting (CABG) is associated with increased risk for morbidity and mortality. Transcatheter aortic valve implantation (TAVI) is an alternative for patients with aortic stenosis, but the outcomes of patients with a history of CABG are unknown. The aim of this study was to explore the association between previous CABG and the outcome of patients undergoing TAVI. Out of 372 consecutive patients who underwent TAVI from 2007 to 2013, 122 (32.8%) had previous CABG, whereas 250 (67.2%) did not. A comparison was made between groups. Subgroup analysis compared patients with and without previous CABG in 3 patient subsets: inoperable, operable, and those who underwent transapical TAVI. Patients with previous CABG were younger (81.99±6.78 vs 84.81±7.06 years, respectively, p<0.001). These patients also had more high-risk features (e.g., peripheral vascular disease, previous myocardial infarction, past cerebrovascular disease, and lower average left ventricular ejection fraction (p<0.05 for all). Procedural aspects were mostly similar between groups. No disparities in mortality rates at 1 year were noted (22.1% vs 21.6%, respectively, p=0.91). Subgroup analyses yielded similar outcomes for all 3 groups. In conclusion, although patients with previous CABG present with more high-risk features, they share similar short- and long-term outcomes with patients without previous CABG, irrespective of their surgical risk. This includes patients who underwent transapical access. TAVI in patients with previous CABG is safe and does not confer a significant risk for adverse outcome.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24513466     DOI: 10.1016/j.amjcard.2013.12.029

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Comparison of midterm outcomes of transcatheter aortic valve implantation in patients with and without previous coronary artery bypass grafting.

Authors:  Hideyuki Kawashima; Yusuke Watanabe; Ken Kozuma; Akihisa Kataoka; Makoto Nakashima; Hirofumi Hioki; Fukuko Nagura; Yugo Nara; Shinichi Shirai; Norio Tada; Motoharu Araki; Toru Naganuma; Futoshi Yamanaka; Hiroshi Ueno; Minoru Tabata; Kazuki Mizutani; Akihiro Higashimori; Kensuke Takagi; Masanori Yamamoto; Kentaro Hayashida
Journal:  Heart Vessels       Date:  2018-04-21       Impact factor: 2.037

2.  Transapical transcatheter aortic valve replacement in patients with or without prior coronary artery bypass graft operation.

Authors:  Konstantinos V Voudris; S Chiu Wong; Ryan Kaple; Polydoros N Kampaktsis; Andreas R de Biasi; Jonathan S Weiss; Richard Devereux; Karl Krieger; Luke Kim; Rajesh V Swaminathan; Dmitriy N Feldman; Harsimran Singh; Nikolaos J Skubas; Robert M Minutello; Geoffrey Bergman; Arash Salemi
Journal:  J Cardiothorac Surg       Date:  2016-11-29       Impact factor: 1.637

Review 3.  Transcatheter versus Surgical Aortic Valve Replacement after Previous Cardiac Surgery: A Systematic Review and Meta-Analysis.

Authors:  Sharaf-Eldin Shehada; Yacine Elhmidi; Öznur Öztürk; Markus Kasel; Antonio H Frangieh; Fanar Mourad; Jaroslav Benedik; Jaafar El Bahi; Mohamed El Gabry; Matthias Thielmann; Heinz Jakob; Daniel Wendt
Journal:  Cardiol Res Pract       Date:  2018-04-05       Impact factor: 1.866

4.  Association between transcatheter aortic valve implantation or replacement and mortality, and major adverse events after coronary artery bypass grafting.

Authors:  Yue Zheng; Tong Li
Journal:  Int J Cardiol Heart Vasc       Date:  2018-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.